The International Monetary Fund's projection that the Iran war will erode global growth arrives at a moment when biopharma M&A is experiencing one of its strongest runs in years — and the collision of these forces is not a brake on dealmaking, but an accelerant. Institutional capital is reading macr
Information
- Show
- FrequencyUpdated Daily
- PublishedApril 9, 2026 at 6:00 AM UTC
- Length19 min
- Episode197
- RatingClean
